In this study, synthesis of some new 1,2,3-triazole derived potential scaffold type peptidomimetics are described.
INTRODUCTION
Peptides are used very often for the development of new therapeutics. However since they have some disadvantages in the direct usage as drugs, they are modified into mimetics and these are called peptidomimetics which are derived from peptides by partly or completely removing the amide bonds while retaining essential amino acid side chains in a defined, spatial relationship (1) (2) (3) . Peptidomimetics are usually prepared by the attachment of active amino acid side chains to a central core, these so called scaffold type peptidomimetics have usually two to eight amino acid residues on a central rigid core. Different type of central cores are described in the literature (1) (2) (3) . Some heterocyclic rings are also chosen in some studies (4) (5) (6) (7) because of their inflexible structures. Imidazol (8) , pyrazole (9-10), 1,2,4-triazole (11) (12) (13) (14) and tetrazol (15) (16) (17) derivatives are the examples of this kind of peptidomimetics.
Triazoles, like many other five membered heterocyclic compounds are used very often in the pharmacological and medicinal applications. Mainly there are two different methods to prepare 1,2,3-triazole derivatives; condensation of amine derivatives with a-diazo-l,3-dicarbonyl compounds (18, 19) or condensation of acetylene compounds with azide derivatives (20) .
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RESULTS AND DISCUSSIONS
In this study, 16 new 1,2,3-triazole derived potential scaffold peptidomimetics were prepared. Our strategy for the synthesis, follows the "dendroid" approach (21, 22) . This strategy involves placement of mimetics of the key residues around a central core. This placement of mimetics might mimic ß-turn form of a peptide. Such a system is shown in Scheme compound 5.
Since the 1,2,3-triazole ring has a rigid structure which can handle the amino acid side chains in a well defined direction and are potentially bioactive compounds, they were chosen for the peptidomimetic templates.
1,2,3-triazoles 3,4 were formed by the reaction of α-diazo-ß-oxoaldehyde la and α-diazo-ß-oxoester lb derivatives with different amine compounds 2 and synthesized potential peptidomimetic precursors were derivatized to yield new potential peptidomimetics 5 (Scheme). Substituents of triazole compounds were chosen as amino acid side chains or their precursors. The results are summarized in Table 1 .
α-Diazo-ß-oxoaldehyde la derivatives were synthesized by Vilsmeier-Haack formylation of 2-diazo-lethanone derivatives [23, 24] and α-Diazo-ß-oxoester compounds lb were synthesized by the diazo group transfer to the ß-oxoester derivatives with tosylazide [23] .
Some conformational flexibility is formed on the synthesised 1,2,3-triazoles by the aryl ether linkages. In this study, acidic (-COOH), phenolic (-C 6 H 4 OH), alcoholic (-CH 2 OH), basic (-C(NH 2 )=NH) and lipophilic (-CH(CH 3 )2, -CH 3 , -C 6 H 5 ) groups were attached on the 1,2,3-triazole core unit. Tyrosine, is mimiced by para-substituted phenol; leucine, is mimiced by isopropyl group; serine, is mimiced by hydroxymethyl group; arginine, is mimiced by para-benzamidino group; phenyl alanine and alanine, are mimiced by phenyl and methyl groups; and glutamic acid and aspartic acid are mimiced by para-substituted benzoic acid. 
EXPERIMENTAL
Melting points were determined on a Electrothermal 9100 capillary melting point apparatus. Infrared spectra were obtained from films on sodium chloride discs for liquids or potassium bromide pellets for solids on a Jasco 5300 FT-IR recording spectrophotometer. The 'H and 13 C-NMR spectra were recorded on a Bruker 250
MHz and are reported in δ units with tetramethylsilane as internal standard. Mass spectra VG-Zabspec (70 ev).
General:All diazo compounds were prepared as described in (12, 13) . Spectroscopic datas of the synthesised compounds are shown in Table 2 .
Synthesis of Compounds 3:10 mmol la was dissolved in 20 ml of EtOH, and a mixture of 10.1 mmol amine compound 2 and 10.1 mmol AcOH were added. The mixture was stirred at r.t. for 4 hr. During this time, the product precipitated and recyristallised from EtOH. The yields are given in 
Synthesis of l-[4-(4-methoxybenzyloxy)phenyl]-4-hydroxymethyl-lH-l,2,3-triazol (5b), l-[2-(4-methoxybenzyloxy)phenyl]-4-hydroxymethyl-l H-l ,2,3-triazol (5f) and l-[4-(4-methoxybenzyloxy)phenyl]-4-
benzoyl-lH-l,2,3-triazol (5g): NaH (11.8 mmol) is added in a solution of phenol compound (5a or 5e or 3b) (11.8 mmol) in DMF (20 mL) under nitrogen atmosphere. After stirring for 10 min. a solution of p-methoxy benzylchloride (2.32 g, 11.8 mmol) in DMF (10 mL) is added to this mixture and stirred at room temperature for 4 hr. Water (200 mL) is added and precipated product is filtered. The product is crystallized from ethanol. The thioamide ( from previous reaction ), was dissolved in a solution of acetone-iodomethane ( 30 ml-2 ml).
Synthesis of l-[4-(4-cyanobenzyloxy)phenyl]-4-hydroxymethyl-lH-l,2,3-triazol (5c):
The reaction mixture was warmed to achive reflux for 5 hours. Concentration in vacuo afforted the thioimidate as the HI salt. The raw mixture was used for the next step without further purification. (167-169 0 C decomposition.) A solution of the thioimidate ( from previous reaction ) and ammomium acetate (2 g) in methanol (150 ml) was warmed to achieve reflux for 8 h. After cooling to room temperature, the reaction mixture was concentrated under a steady stream of nitrogen, then acetone ( 200 ml) was added and precipitated product was filtrated. 
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